-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LxKpwTOnDwrgecprgh9tavF1ou8RU9ailP4DI3HC28N5XqaLX8Hmx5CXQoUrKIF4 yoH7cNGDSbdsQLquuIjfMA== 0001169232-03-006207.txt : 20031028 0001169232-03-006207.hdr.sgml : 20031028 20031028120443 ACCESSION NUMBER: 0001169232-03-006207 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20031028 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-57907 FILM NUMBER: 03960109 BUSINESS ADDRESS: STREET 1: 865 LONGBOAT KEY CLUB ROAD CITY: LONGBOAT KEY STATE: FL ZIP: 34228 BUSINESS PHONE: 8124797266 MAIL ADDRESS: STREET 1: 865 LONGBOAT KEY CLUB ROAD CITY: LONGBOAT KEY STATE: FL ZIP: 34228 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: STONESTREET LTD PARTNERSHIP CENTRAL INDEX KEY: 0001143971 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 260 TOWN CENTRE BLVD SUITE 201 STREET 2: MARKHAM ONTARIO BUSINESS PHONE: 4168676089 MAIL ADDRESS: STREET 1: 260 TOWNE CENTRE BLVD SUITE 201 STREET 2: MARKHAM ONTARIO SC 13G/A 1 d57213_sc13ga.txt AMENDMENT NO. 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------- SCHEDULE 13G Information Statement pursuant to Rule 13d-1 (Amendment No. 1) ---------- BioDelivery Sciences International, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 09060J106 (CUSIP Number) October 23, 2003 (Date of event which requires filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |X| Rule 13d-1(c) |_| Rule 13d-1(d) (Continued on following pages) (Page 1 of 4) Page 2 of 4 - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Stonestreet, L.P. - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Canada - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES 336,600 ----------------------------------------------------------------- BENEFICIALLY 6. SHARED VOTING POWER OWNED BY None ----------------------------------------------------------------- EACH 7. SOLE DISPOSITIVE POWER REPORTING 336,600 ----------------------------------------------------------------- PERSON 8. SHARED DISPOSITIVE POWER WITH None - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 336,600 - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_| - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.8% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- Item 1(a). Name of Issuer. BioDelivery Sciences International, Inc. Item 1(b). Address of Issuer's Principal Executive Offices. 185 South Orange Avenue, Administrative Building 4 Newark, New Jersey 07103 Item 2(a). Names of Person Filing. Stonestreet, L.P. Item 2(b). Address of Principal Business Office, or if none, Residence. The address of the principal business office of Stonestreet L.P. is: 260 Town Centre Blvd. Suite 201 Markham, ON L3R 8H8 Canada Item 2(c). Citizenship. Stonestreet, L.P. is a Canadian Limited Partnership. Item 2(d). Title of Class of Securities. Common Stock Page 3 of 4 Item 2(e). CUSIP Number. 09060J106 Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b), check whether the person filing is a: Not applicable. This statement is filed pursuant to Rule 13d-1(c) Item 4. Ownership. (a) Amount beneficially owned by reporting person: 336,600 shares of Common Stock of the Issuer. (b) Percent of Class: 4.8% (based on 6,985,863 shares of Common Stock of the Issuer issued and outstanding as of August 14, 2003 as stated in the Issuer's Form 10-QSB filed on August 14, 2003). (c) Number of shares as to which such person has: (i) Sole power to direct the vote: 336,600 shares of Common Stock of the Issuer. (ii) Shared power to vote or to direct the vote: None (iii) Sole power to dispose or direct the disposition of the Common Stock: 336,600 shares of Common Stock of the Issuer. (iv) Shared power to dispose or direct the disposition of: None Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [x]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction which could have that purpose or effect. Page 4 of 4 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: October 27, 2003 Stonestreet, L.P. By: /s/ Michael Finkelstein Michael Finkelstein President -----END PRIVACY-ENHANCED MESSAGE-----